Bellerophon Therapeutics competitors
Bellerophon Therapeutics's competitors include Hedgepath Pharmaceuticals, Cellestia Biotech, Deciphera Pharmaceuticals and UNITY Biotechnology
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. |  Hedgepath Pharmaceuticals HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer. |  Cellestia Biotech Cellestia Biotech is a private biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway. |  UNITY Biotechnology Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging. | |
Founding Date | Founding Date 2009 | Founding Date 1992 | Founding Date 2014 | Founding Date 2003 | Founding Date 2009 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Warren, US HQ | Locations Tampa, US HQ | Locations Lausanne, CH HQ Basel, CH | Locations Waltham, US HQ Lawrence, US | Locations San Francisco, US HQ |
Employees | Employees 22 | Employees 9 | Employees 6 | Employees 438% increase | Employees 7 |
Valuation ($) | Valuation ($) 164.9 m | Valuation ($) 133.1 m | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 637.2 m |
Twitter followers | Twitter followers N/A | Twitter followers 57 | Twitter followers 64 | Twitter followers N/A | Twitter followers 593 |
Financial ⚠ | |||||
Net income | Net income ($7.4m) (FY, 2016) | Net income N/A | Net income N/A | Net income ($25.9m) (FY, 2016) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 80m | Total funding raised N/A | Total funding raised $ 8m | Total funding raised $ 142m | Total funding raised $ 208.8m |
For sources of this data, please see the company profileDownload Excel
View company profiles
Hedgepath Pharmaceuticals
HQ
Tampa, US
Employees
9
HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.
View companyCellestia Biotech
HQ
Lausanne, CH
Employees
6
Cellestia Biotech is a private biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
View company
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
43↑ 8% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company.
View companyUNITY Biotechnology
HQ
San Francisco, US
Employees
7
Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging.
View company